Cargando…
Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
Although docetaxel (DTX) confers significant survival benefits in patients with castration‐resistant prostate cancer (CRPC), resistance to DTX inevitably occurs. Therefore, clarifying the mechanisms of DTX resistance may improve survival in patients with CRPC. Claspin plays a pivotal role in DNA rep...
Autores principales: | Babasaki, Takashi, Sentani, Kazuhiro, Sekino, Yohei, Kobayashi, Go, Thang Pham, Quoc, Katsuya, Narutaka, Akabane, Shintaro, Taniyama, Daiki, Hayashi, Tetsutaro, Shiota, Masaki, Oue, Naohide, Teishima, Jun, Matsubara, Akio, Yasui, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366092/ https://www.ncbi.nlm.nih.gov/pubmed/34240817 http://dx.doi.org/10.1002/cam4.4113 |
Ejemplares similares
-
Claspin overexpression is associated with high‐grade histology and poor prognosis in renal cell carcinoma
por: Kobayashi, Go, et al.
Publicado: (2020) -
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019) -
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
por: Pham, Quoc Thang, et al.
Publicado: (2021) -
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
por: Pham, Quoc Thang, et al.
Publicado: (2021) -
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)